Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 15, 2022 at 03:37 am IST
Accelerate Diagnostics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 2.96 million compared to USD 3.12 million a year ago. Net loss was USD 15.71 million compared to USD 8.99 million a year ago. Basic loss per share from continuing operations was USD 1.8 compared to USD 1.5 a year ago.
For the nine months, sales was USD 9.78 million compared to USD 8.44 million a year ago. Net loss was USD 47.69 million compared to USD 54.9 million a year ago. Basic loss per share from continuing operations was USD 6.2 compared to USD 9.1 a year ago.